JÜNGEL, Eva, ERB, Holger Hans Hermann, HAFERKAMP, Axel, RUTZ, Jochen, CHUN, Felix und BLAHETA, Roman A., 2018. Relevance of the natural HDAC inhibitor sulforaphane as a chemopreventive agent in urologic tumors. Amsterdam: Elsevier.
Elsevier - Harvard (with titles)Jüngel, E., Erb, H.H.H., Haferkamp, A., Rutz, J., Chun, F., Blaheta, R.A., 2018. Relevance of the natural HDAC inhibitor sulforaphane as a chemopreventive agent in urologic tumors, Cancer Letters. Elsevier, Amsterdam. https://doi.org/10.1016/j.canlet.2018.07.017
American Psychological Association 7th editionJüngel, E., Erb, H. H. H., Haferkamp, A., Rutz, J., Chun, F., & Blaheta, R. A. (ca. 2018). Relevance of the natural HDAC inhibitor sulforaphane as a chemopreventive agent in urologic tumors [Cd]. In Cancer Letters. Elsevier. https://doi.org/10.1016/j.canlet.2018.07.017
Springer - Basic (author-date)Jüngel E, Erb HHH, Haferkamp A, Rutz J, Chun F, Blaheta RA (2018) Relevance of the natural HDAC inhibitor sulforaphane as a chemopreventive agent in urologic tumors. Elsevier, Amsterdam
Juristische Zitierweise (Stüber) (Deutsch)Jüngel, Eva/ Erb, Holger Hans Hermann/ Haferkamp, Axel/ Rutz, Jochen/ Chun, Felix/ Blaheta, Roman A., Relevance of the natural HDAC inhibitor sulforaphane as a chemopreventive agent in urologic tumors, Amsterdam 2018.